Anti-herpes simplex virus activities of two novel disulphated cyclitols

Antiviral Chemistry and Chemotherapy

Volumn 17, Issue 2, 2006, Pages 97-106

  Ekblad, Maria ^a   Bergström, Tomas ^a   Banwell, Martin G ^b   Bonnet, Muriel ^b   Renner, Jens ^b   Ferro, Vito ^c   Trybala, Edward ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c Progen Pharmaceuticals Limited   (Australia)

Author keywords

Antiviral potential; Disulphated cyclitols; Herpes simplex virus

Indexed keywords

ANTIVIRUS AGENT; CYCLITOL DERIVATIVE; POLYSACCHARIDE; SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 33646463162     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020601700205     Document Type: Article

References (21)

1. Abrams DI, Kuno S, Wong R, Jeffords K, Nash M, Molaghan JB, Gorter R & Ueno R (1989) Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Annals of Internal Medicine 110:183-188.
2. Artmann C, Roding J, Ghyczy M & Pratzel HG (1990) Liposomes from soya phospholipids as percutaneous drug carriers. 2nd communication: quantitative in vivo investigations with radioactively labelled liposomes. Arzneimittelforschung 40:1365-1368.
3. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J & De Clerq E (1988) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proceedings of the National Academy of Sciences, USA 85:6132-6136.
4. Betz G, Nowbakht P, Imboden R & Imanidis G (2001) Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro. International Journal of Pharmacology 228:147-159.
5. Duff R & Rapp F (1971) Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature New Biology 233:48-50.
6. Gong Y, Wen A, Cheung D, Wong M & Sacks SL (2001) Preclinical evaluation of docusate as protective agent from herpes simplex viruses. Antiviral Research 52:25-32.
7. Gunalp A (1965) Growth and cytopathic effect of rubella virus in a line of Green Monkey kidney cells. Proceedings of the Society for Experimental Biology and Medicine 118:185-190.
8. Holland TC, Homma FL, Marlin SD, Levine M & Glorioso J (1984) Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. Journal of Virology 52:566-574.
9. Isaacs CE, Jia JH & Xu W (2004) A lipid-peptide microbicide inactivates herpes simplex virus. Antimicrobial Agents and Chemotherapy 48:3182-3184.
10. John M, Keller MJ, Fam EH, Cheshenko N, Hogarty K, Kasowitz A, Wallenstein S, Carlucci MJ, Tuyama AC, Lu W, Klotman ME, Lehrer RI & Herold BC (2005) Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. Journal of Infectious Diseases 192:1731-1740
11. Karger A & Mettenleiter TC (1993) Glycoproteins gill and gp50 play a dominant role in the biphasic attachment of pseudorabies virus. Virology 194:654-664.
12. Lee E, Pavy M, Young N, Freeman C & Lobigs M (2006) Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Research 69:31-38.
13. Lorentsen KJ, Hendrix CW, Collins JM, Kornhauser DM, Petty BG, Klecker RW, Flexner C, Eckel RH & Lietman PS (1989) Dextran sulfate is poorly absorbed after oral administration. Annals of Internal Medicine 111:561-566.
14. Neyts J & De Clercq E (1995) Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10:8-12.
15. Nyberg K, Ekblad M, Bergstrom T, Freeman C, Parish CR, Ferro V & Trybala E (2004) The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Research 63:15-24.
16. Piret J, Roy S, Gagnon M, Landry S, Desormeaux A, Omar RF & Bergeron MG (2002) Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine. Antimicrobial Agents and Chemotherapy 46:2933-2942.
17. Schnipper LE, Lewin AA, Swartz M & Crumpacker CS (1980) Mechanisms of photodynamic inactivation of herpes simplex viruses: comparison between methylene blue, light plus electricity, and hematoporhyrin plus light. Journal of Clinical Investigation 65:432-438.
18. Takemoto KK & Liebhaber H (1961) Virus-polysaccharide interactions. 1. An agar polysaccharide determining plaque morphology of EMC-virus. Virology 14:436-462.
19. Vaheri A (1964) Heparin and related polyionic substances as virus inhibitors. Acta Pathologica and Microbiologica Scandinavica, Supplement 171:1-98.
20. Witvrouw M & De Clercq E (1997) Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. General Pharmacology 29:497-511.
21. Zacharopoulos VR & Phillips DM (1997) Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clinical and Diagnostic Laboratory Immunology 4:465-468.